[{"Assets_0_Q1_USD":754668000.0,"CommonStockSharesOutstanding_0_Q1_shares":21301980.0,"EarningsPerShareBasic_1_Q1_USD":2.13,"EarningsPerShareDiluted_1_Q1_USD":1.83,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":60761000.0,"NetIncomeLoss_1_Q1_USD":45279000.0,"StockholdersEquity_0_Q1_USD":481100000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":24800314.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":21209000.0,"Ticker":"LGND","CIK":"886163","name":"LIGAND PHARMACEUTICALS INC","OfficialName":"Ligand Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1738856427.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]